Mitochondrial impact on nerve growth factor production in vascular smooth muscle-derived cells.

[1]  J. Tuttle,et al.  Increased nerve growth factor mRNA stability may underlie elevated nerve growth factor secretion from hypertensive vascular smooth muscle cells. , 1998, Brain research. Molecular brain research.

[2]  W. Steers,et al.  Arterial nerve growth factor (NGF) mRNA, protein, and vascular smooth muscle cell NGF secretion in hypertensive and hyperactive rats. , 1998, Experimental cell research.

[3]  S. Tabrizi,et al.  The influence of nuclear background on the biochemical expression of 3460 Leber's hereditary optic neuropathy , 1998, Annals of neurology.

[4]  J. Cooper,et al.  Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease , 1998, Annals of neurology.

[5]  I. Nakano,et al.  Effects of repeated systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to mice on interleukin-1β and nerve growth factor in the striatum , 1998, Neuroscience Letters.

[6]  G. R. Hankins,et al.  Mechanisms of increased NGF production in vascular smooth muscle of the spontaneously hypertensive rat. , 1998, Experimental cell research.

[7]  Keli Xu,et al.  Calcium oscillations increase the efficiency and specificity of gene expression , 1998, Nature.

[8]  J. Bauer,et al.  NF‐κB modulates lipopolysaccharide‐induced microglial nerve growth factor expression , 1998 .

[9]  Margaret A. Johnson,et al.  Role of mitochondrial DNA mutations in human aging: Implications for the central nervous system and muscle , 1998, Annals of neurology.

[10]  Massimo Zeviani,et al.  Cytochrome c Oxidase subunit I microdeletion in a patient with motor neuron disease , 1998, Annals of neurology.

[11]  R. Morais,et al.  Cloning and characterization of cDNAs encoding chicken mitogen-activated protein kinase kinase type 2, MEK2: downregulation of MEK2 in response to inhibition of mitochondrial DNA expression. , 1997, Biochemistry.

[12]  C. Fall,et al.  Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease. , 1997, Biochimica et biophysica acta.

[13]  R. Davis,et al.  Cybrids in Alzheimer's disease: A cellular model of the disease? , 1997, Neurology.

[14]  V. Ingram,et al.  Compromised mitochondrial function leads to increased cytosolic calcium and to activation of MAP kinases. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[15]  W. Steers,et al.  Thrombin regulates nerve growth factor secretion from vascular, but not bladder smooth muscle cells , 1997, Cell and Tissue Research.

[16]  B. Ames,et al.  Mitochondrial decay in hepatocytes from old rats: membrane potential declines, heterogeneity and oxidants increase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Robert E. Davis,et al.  Altered Calcium Homeostasis in Cells Transformed by Mitochondria from Individuals with Parkinson's Disease , 1997, Journal of neurochemistry.

[18]  B. Hille,et al.  Mitochondrial Participation in the Intracellular Ca2+ Network , 1997, The Journal of cell biology.

[19]  H. Forman,et al.  Oxidants as stimulators of signal transduction. , 1997, Free radical biology & medicine.

[20]  A. Rabson,et al.  Regulation of Nerve Growth Factor mRNA by Interleukin-1 in Rat Hippocampal Astrocytes Is Mediated by NFκB* , 1996, The Journal of Biological Chemistry.

[21]  T. Helling,et al.  Changes in adenine nucleotides during hemorrhagic shock and reperfusion. , 1996, The Journal of surgical research.

[22]  R. Swerdlow,et al.  Origin and functional consequences of the complex I defect in Parkinson's disease , 1996, Annals of neurology.

[23]  P. Cartwright,et al.  Selective induction of mitochondrial chaperones in response to loss of the mitochondrial genome. , 1996, European journal of biochemistry.

[24]  J. Bénavidès,et al.  Transduction Mechanisms Involved in Thrombin Receptor‐Induced Nerve Growth Factor Secretion and Cell Division in Primary Cultures of Astrocytes , 1996, Journal of neurochemistry.

[25]  E. Friedman,et al.  Increased Expression of Protein Kinase C Activates ERK3 (*) , 1996, The Journal of Biological Chemistry.

[26]  C. Sen,et al.  Antioxidant and redox regulation of gene transcription , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  A. Colangelo,et al.  Correlation between increased AP-1NGF binding activity and induction of nerve growth factor transcription by multiple signal transduction pathways in C6-2B glioma cells. , 1996, Brain research. Molecular brain research.

[28]  V. Gogvadze,et al.  Nitric oxide (nitrogen monoxide, NO) stimulates insulin secretion by inducing calcium release from mitochondria. , 1995, Biochemical and biophysical research communications.

[29]  H. Thoenen.  Neurotrophins and Neuronal Plasticity , 1995, Science.

[30]  V. Ferrans,et al.  Requirement for Generation of H2O2 for Platelet-Derived Growth Factor Signal Transduction , 1995, Science.

[31]  T. Torgerson,et al.  Inhibition of Nuclear Translocation of Transcription Factor NF-κB by a Synthetic Peptide Containing a Cell Membrane-permeable Motif and Nuclear Localization Sequence (*) , 1995, The Journal of Biological Chemistry.

[32]  S. Pshenichkin,et al.  Okadaic Acid Increases Nerve Growth Factor Secretion, mRNA Stability, and Gene Transcription in Primary Cultures of Cortical Astrocytes (*) , 1995, The Journal of Biological Chemistry.

[33]  H. Reichmann,et al.  Electron transport chain defects in Alzheimer's disease. , 1994, Neurology.

[34]  F. Vaillant,et al.  Up-regulation of the plasma membrane oxidoreductase as a prerequisite for the viability of human Namalwa rho 0 cells. , 1994, The Journal of biological chemistry.

[35]  D. Friel,et al.  An FCCP-sensitive Ca2+ store in bullfrog sympathetic neurons and its participation in stimulus-evoked changes in [Ca2+]i , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[36]  Samuel Thayer,et al.  Mitochondria buffer physiological calcium loads in cultured rat dorsal root ganglion neurons , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[37]  J. Gerrard,et al.  Post-receptor events associated with thrombin-induced platelet activation. , 1993, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[38]  P. Lapchak.  Nerve Growth Factor Pharmacology: Application to the Treatment of Cholinergic Neurodegeneration in Alzheimer's Disease , 1993, Experimental Neurology.

[39]  W. Fiers,et al.  Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene‐inductive effects of TNF. , 1993, The EMBO journal.

[40]  H. Dekker,et al.  Mitochondria in cultured human muscle cells depleted of mitochondrial DNA. , 1993, European Journal of Cell Biology.

[41]  M. James-Kracke.  Quick and accurate method to convert BCECF fluorescence to pHi: Calibration in three different types of cell preparations , 1992, Journal of cellular physiology.

[42]  R. Houlgatte,et al.  Activation of nerve growth factor synthesis in primary glial cells by phorbol 12-myristate 13-acetate: role of protein kinase C , 1992, Brain Research.

[43]  D. Creedon,et al.  Nerve Growth Factor Synthesis in Vascular Smooth Muscle , 1991, Hypertension.

[44]  K. Griendling,et al.  Thrombin signal transduction mechanisms in rat vascular smooth muscle cells. Calcium and protein kinase C-dependent and -independent pathways. , 1990, The Journal of biological chemistry.

[45]  R. Houlgatte,et al.  Phorbol 12‐myristate 13‐acetate (PMA) increases the expression of the nerve growth factor (NGF) gene in mouse L‐929 fibroblasts , 1990, FEBS letters.

[46]  M. King,et al.  Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. , 1989, Science.

[47]  Sangkot Marzuki,et al.  MITOCHONDRIAL DNA MUTATIONS AS AN IMPORTANT CONTRIBUTOR TO AGEING AND DEGENERATIVE DISEASES , 1989, The Lancet.

[48]  R. Levi‐montalcini,et al.  The nerve growth factor 35 years later. , 1987, Science.

[49]  R. Tsien,et al.  A new generation of Ca2+ indicators with greatly improved fluorescence properties. , 1985, The Journal of biological chemistry.

[50]  R. Paul,et al.  Compartmentation of glycolytic and glycogenolytic metabolism in vascular smooth muscle. , 1983, Science.

[51]  A. Lehninger,et al.  Sites of inhibition of mitochondrial electron transport in macrophage- injured neoplastic cells , 1982, The Journal of cell biology.

[52]  R. Estabrook.  [7] Mitochondrial respiratory control and the polarographic measurement of ADP : O ratios , 1967 .